Johnson Investment Counsel Inc. Has $2.45 Million Stock Holdings in U.S. Physical Therapy, Inc. $USPH

Johnson Investment Counsel Inc. grew its stake in shares of U.S. Physical Therapy, Inc. (NYSE:USPH) by 35.1% in the third quarter, according to the company in its most recent filing with the SEC. The firm owned 28,794 shares of the company’s stock after acquiring an additional 7,477 shares during the quarter. Johnson Investment Counsel Inc. owned about 0.19% of U.S. Physical Therapy worth $2,446,000 as of its most recent SEC filing.

A number of other hedge funds also recently modified their holdings of USPH. Royal Bank of Canada lifted its position in U.S. Physical Therapy by 3.4% during the first quarter. Royal Bank of Canada now owns 79,238 shares of the company’s stock worth $5,733,000 after purchasing an additional 2,594 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its position in shares of U.S. Physical Therapy by 4.6% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 8,897 shares of the company’s stock valued at $644,000 after buying an additional 391 shares in the last quarter. Jane Street Group LLC lifted its holdings in shares of U.S. Physical Therapy by 249.3% during the 1st quarter. Jane Street Group LLC now owns 49,309 shares of the company’s stock worth $3,568,000 after acquiring an additional 35,191 shares during the period. Callan Family Office LLC bought a new stake in shares of U.S. Physical Therapy during the 2nd quarter worth approximately $423,000. Finally, CWM LLC boosted its position in shares of U.S. Physical Therapy by 207.4% during the 2nd quarter. CWM LLC now owns 827 shares of the company’s stock worth $65,000 after acquiring an additional 558 shares in the last quarter.

Analyst Upgrades and Downgrades

USPH has been the subject of several research analyst reports. Citigroup restated a “market outperform” rating on shares of U.S. Physical Therapy in a research report on Monday, December 15th. Barrington Research reiterated an “outperform” rating and issued a $103.00 price target on shares of U.S. Physical Therapy in a research note on Monday, January 5th. JPMorgan Chase & Co. dropped their price objective on U.S. Physical Therapy from $110.00 to $100.00 and set an “overweight” rating for the company in a research report on Monday, November 24th. Finally, Weiss Ratings reaffirmed a “hold (c)” rating on shares of U.S. Physical Therapy in a research note on Wednesday, January 21st. Four investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $105.33.

U.S. Physical Therapy Stock Performance

NYSE USPH opened at $88.19 on Thursday. The firm’s fifty day moving average price is $82.04 and its two-hundred day moving average price is $81.89. The stock has a market cap of $1.34 billion, a PE ratio of 37.06, a PEG ratio of 3.52 and a beta of 1.30. The company has a debt-to-equity ratio of 0.30, a quick ratio of 1.20 and a current ratio of 1.20. U.S. Physical Therapy, Inc. has a fifty-two week low of $62.77 and a fifty-two week high of $93.50.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc (NYSE: USPH) is a leading owner and operator of outpatient physical therapy clinics across the United States. The company delivers rehabilitative care to patients recovering from orthopedic injuries, neurological disorders and chronic conditions. Its core services include one-on-one physical therapy sessions, aquatic therapy, occupational therapy, massage therapy and sports medicine programs designed to restore mobility and enhance quality of life.

In addition to traditional rehabilitation services, U.S.